Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

PR Newswire

GAITHERSBURG, Md., April 29, 2026

GAITHERSBURG, Md., April 29, 2026 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Wednesday, May 6, 2026. Details of the event and replay are as follows:

Conference call details:
Date:	May 6, 2026
Time:	8:30 a.m. ET
URL to register phone:	Register Here
Dial-in number:	(888) 880-3330 (U.S.) or
	(+1) (646) 357-8766 (International)
Webcast:	ir.novavax.com/events

Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.

Replay details:
Date:	Available starting at 11:30 a.m. ET, May 6, 2026, until 11:59 p.m. ET, May 13, 2026
Dial-in number:	(800) 770-2030 (U.S.) or
	(+1) (609) 800-9909 (International)
Passcode:	1309751#
Webcast:	ir.novavax.com/events, until June 6, 2026

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world’s most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M^® adjuvant and protein-based nanoparticles. The Company’s growth strategy focuses on maximizing the impact of its cutting-edge technology by forging strategic partnerships for its Matrix-M adjuvant and R&D assets. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors
Jim Kelly
844-668-2829
ir@novavax.com

Media
Yvonne Sprow
844-264-8571
media@novavax.com